Status:
COMPLETED
Pharmacogenomic Research in Korean Patients With Hepatitis C
Lead Sponsor:
Inje University
Conditions:
Chronic Hepatitis C
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to investigate the relationships between drug response and the host genetic factors, viral factors and clinical factors in chronic hepatitis C patients (HCV). And thus, the in...
Eligibility Criteria
Inclusion
- Hepatitis C virus infected patients
Exclusion
- Patients who infected Hepatitis B virus or Human immunodeficiency virus
- HCV infected patients previously treated with antiviral drugs
- Patients had a history of autoimmune hemolytic anemia
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
373 Patients enrolled
Trial Details
Trial ID
NCT01453244
Start Date
July 1 2011
End Date
March 1 2013
Last Update
June 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inje University
Busan, South Korea, 633-165